1. Home
  2. CERS vs AMCX Comparison

CERS vs AMCX Comparison

Compare CERS & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • AMCX
  • Stock Information
  • Founded
  • CERS 1991
  • AMCX 1980
  • Country
  • CERS United States
  • AMCX United States
  • Employees
  • CERS N/A
  • AMCX N/A
  • Industry
  • CERS EDP Services
  • AMCX Cable & Other Pay Television Services
  • Sector
  • CERS Technology
  • AMCX Telecommunications
  • Exchange
  • CERS Nasdaq
  • AMCX Nasdaq
  • Market Cap
  • CERS 271.4M
  • AMCX 292.9M
  • IPO Year
  • CERS 1997
  • AMCX 2011
  • Fundamental
  • Price
  • CERS $1.50
  • AMCX $6.19
  • Analyst Decision
  • CERS Strong Buy
  • AMCX Sell
  • Analyst Count
  • CERS 2
  • AMCX 5
  • Target Price
  • CERS $3.50
  • AMCX $6.50
  • AVG Volume (30 Days)
  • CERS 1.4M
  • AMCX 559.8K
  • Earning Date
  • CERS 07-31-2025
  • AMCX 08-08-2025
  • Dividend Yield
  • CERS N/A
  • AMCX N/A
  • EPS Growth
  • CERS N/A
  • AMCX N/A
  • EPS
  • CERS N/A
  • AMCX N/A
  • Revenue
  • CERS $185,144,000.00
  • AMCX $2,380,086,000.00
  • Revenue This Year
  • CERS $24.95
  • AMCX N/A
  • Revenue Next Year
  • CERS $8.48
  • AMCX N/A
  • P/E Ratio
  • CERS N/A
  • AMCX N/A
  • Revenue Growth
  • CERS 13.06
  • AMCX N/A
  • 52 Week Low
  • CERS $1.12
  • AMCX $5.41
  • 52 Week High
  • CERS $2.54
  • AMCX $11.57
  • Technical
  • Relative Strength Index (RSI)
  • CERS 54.05
  • AMCX 49.43
  • Support Level
  • CERS $1.31
  • AMCX $5.90
  • Resistance Level
  • CERS $1.46
  • AMCX $6.44
  • Average True Range (ATR)
  • CERS 0.07
  • AMCX 0.29
  • MACD
  • CERS 0.00
  • AMCX -0.00
  • Stochastic Oscillator
  • CERS 65.79
  • AMCX 37.68

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

Share on Social Networks: